Association Between Liver Function Tests and Acute Kidney Injury in Cardiac Surgery Patients
TransAKI
Association Between Elevated Liver Functions Tests Following Cardiac Surgery and Acute Kidney Injury - a Restrospectiv Single Center Cohort Study
1 other identifier
observational
3,415
1 country
1
Brief Summary
A sudden decline in function of the kidneys is a common problem that can happen after heart surgery. It can have serious effects on a patient's recovery and long-term health, potentially leading to permanent kidney problems or heart-related issues. One of the main reasons kidney problems occurs is due to changes in blood flow caused by the heart not pumping well enough. These changes may harm the kidneys, but other organs as well such as the liver. This study aims to find out if there is a relationship between elevated levels of liver function blood tests and the decline in kidney function.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 6, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 6, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
November 6, 2024
CompletedFirst Submitted
Initial submission to the registry
November 26, 2024
CompletedFirst Posted
Study publicly available on registry
December 12, 2024
CompletedDecember 12, 2024
November 1, 2024
Same day
November 26, 2024
December 11, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Association between liver enzymes and acute kidney injury
Investigation of the association between liver enzymes (alanine aminotransferase (AST); aspartate aminotransferase (ALT)) and development of acute kidney injury. Data about liver enzymes will be collected at ICU admission, and 12 hours and 24 hours after ICU admission. AKI is defined by the Kidney Disease Improving global outcome definition by using both the serum creatinine and urine output criteria.
Data about liver enzymes will be collected at ICU admission, and 12 hours and 24 hours after ICU admission. The occurrence of acute kidney injury within 72 hours after ICU admission will be investigated
Secondary Outcomes (2)
Association between liver enzymes and the severity of acute kidney injury
Data about liver enzymes will be collected at ICU admission, and 12 hours and 24 hours after ICU admission. The occurrence of the different severity stages of acute kidney injury within 72 hours after ICU admission will be investigated
association of central venous pressure with elevated liver enzymes and acute kidney injury
Data about central venous pressure will be collected during the first 24 hours after ICU admission.
Study Arms (1)
Main cohort of patient
In the included patients the occurrence of acute kidney injury (AKI) will be investigated. So patient will be grouped as 'no AKI' and 'AKI' For the subanalysis, patient will be grouped according to their admission central venous pressure. There are no interventions.
Eligibility Criteria
The cardiac surgery patients screened for eligibility were admitted on the cardiac surgery intensive care unit of Ghent University hospital between 1 Januari 2012 until 31 december 2017
You may qualify if:
- years old or older
- admission on intensive care after cardiac surgery
- available data about liver enzymes
You may not qualify if:
- chronic kidney disease with (estimated) glomerular filtration rate below 30mL/min/1.73 m2 or renal replacement therapy (RRT) dependent
- patient on extracorporal membrane oxygenator (ECMO) before or after cardiac surgery
- patient with or planned surgery for Left ventricular assist device (LVAD)
- inotropics or vasopressore before surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ghent university hospital
Ghent, Oost-Vlaanderen, 9000, Belgium
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Wim Vandenberghe, MD; PhD
University Hospital, Ghent
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 26, 2024
First Posted
December 12, 2024
Study Start
November 6, 2024
Primary Completion
November 6, 2024
Study Completion
November 6, 2024
Last Updated
December 12, 2024
Record last verified: 2024-11
Data Sharing
- IPD Sharing
- Will not share
Due to European Data Protection regulation, no individual participant data will be shared, only the analysed data.